CD274 and neoplasm: This enhanced tumor killing and decreased tumor burden compared to treatment with unmodified MBs, anti-PD-L1-MBs, and miR-34a-MBs administered without US by activating apoptosis, evidenced by IHC and terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) immunostains.